Studies have shown that the overexpresseion of HAS1 in bladder cancer cells can cause an increase in the CD44 variant isoforms (HA receptor), thereby inhibite Fas mediated apoptosis (64), and promoting the growth and invasion of bladder cancer cells. This evidence concerns the gene HAS1 and urinary bladder cancer.